| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.570 | 3.924 | 2.971 | 3.069 | 0 | 915 |
| Total Income - EUR | - | - | - | - | 3.570 | 3.924 | 2.971 | 3.069 | 0 | 915 |
| Total Expenses - EUR | - | - | - | - | 5.643 | 6.059 | 6.171 | 6.650 | 758 | 1.142 |
| Gross Profit/Loss - EUR | - | - | - | - | -2.073 | -2.135 | -3.201 | -3.581 | -758 | -228 |
| Net Profit/Loss - EUR | - | - | - | - | -2.109 | -2.174 | -3.231 | -3.612 | -758 | -228 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Marclinic Optim Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 436 | 234 | 33 |
| Current Assets | - | - | - | - | 38 | 39 | 43 | 596 | 369 | 1.043 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 215 | 2 | 917 |
| Cash | - | - | - | - | 38 | 39 | 43 | 380 | 367 | 126 |
| Shareholders Funds | - | - | - | - | -2.067 | -4.201 | -7.339 | -10.974 | -11.699 | -11.861 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 2.104 | 4.240 | 7.382 | 12.005 | 12.301 | 12.936 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Marclinic Optim Med S.r.l.